|
|
Evaluation of clinical effectiveness of Qingrejiedutouzhenfang in treatment of measles |
TU Bo, NIE Weimin, QIN Enqiang, WU Dan, YUAN Hong, ZHOU Zhiping, HUO Dandan, CHEN Weiei, ZHAO Min, and LI Fengyi |
Treatment and Research Center for Infectious Diseases, No. 302 Hospital of PLA, Beijing 100039, China |
|
|
Abstract Objective To evaluate the effectiveness of Qingrejiedutouzhenfang on treatment of measles. Methods Taking prospective, randomized, controlled, open approach, we divided patients into control group(group A,n=30), Qingrejiedutouzhenfang group(group B,n=30) and banlangen (isatis root) group(group C,n=30), and observed clinical effectiveness, complications and adverse reaction incidence. Results Hospitalization time in group B was shorter than that in other two groups(P<0.05). The heating time after treating of group B was shorter than that in group A(P<0.01). The time of fever abatement in group B is shortest, but there was no statistically significant difference among the three groups. One week after treatment, cure rate and effective rate in group A were 53.3% and 73.3%, respectively; cure rate and effective rate in group B were 78.6% and 96.4%, respectively; cure rate and effective rate in group C were 65.5% and 86.2%, respectively. There were statistically significant differences in cure rate and effective rate(P=0.047) among the three groups. Conclusions Qingrejiedutouzhenfang is effective and safe in treatment of measles, and worthy of clinical promotion.
|
Received: 07 June 2015
|
|
|
|
|
[1] |
中华人民共和国卫生部新闻办公室.卫生部公布2011年1月及2010年度全国法定传染病疫情概况[EB/OL].http://www. chinacdc.cn/ tjsj/fdcrbbg/201104/t20110421_42213.htm,2011-4-21.
|
[2] |
中华人民共和国卫生部新闻办公室.卫生部公布2010年1月及2009年度全国法定传染病疫情[EB/OL]. http:// www.moh.gov.cn/publicfiles/business/htmlfiles/mohbgt/s3582/201002/46043.htm,2010-2-10.
|
[3] |
中华人民共和国卫生部新闻办公室.卫生部就麻疹疫苗强化免疫活动举行通气会. http://www.china. com.cn/zhibo/2010-09/01/content_20838101.htm,2010-9-1.
|
[4] |
Moss W J,Griffin D E.Measles[J].Lancet,2012,379(9811):153-164.
|
[5] |
World Health Organization. Global reductions in measles mortality 2000-2008 and the risk of measles resurgence[J]. Wkly Epidemiol Rec,2009,84:509-516.
|
[6] |
Simons E, Ferrari M, Fricks J, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data[J]. Lancet,2012,379:2173-2178.
|
[7] |
Chao Ma, Lixin Hao, Yan Zhang,et al. Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data[J]. Bull World Health Organ,2014,92:340-347.
|
[8] |
杨白娥, 霍兆连.试论麻疹的辨治体会[J].陕西中医,2002, 23(6):573-574.
|
[9] |
李良元.中西医结合治疗麻疹并发脑炎59 例疗效观察[J].中国中医药信息杂志,2003,10(10):70-71.
|
[10] |
唐军莉.中医辨治成人麻疹并发肺炎18例[J].现代中西医结合杂志,2011,33:4252.
|
|
|
|